are glp-1 safe Good News: Medications in Type 1 Diabetes Look and Promising GLP-1 agonists are often called

Your choice of Part D plan will matter more than ever

ACC: p = 0.449

References: GLP-1 Single, Dual, and Triple Receptor Agonists The Lancet eClinicalMedicine 2024 GLP-1 Receptor Agonists State of the Art PMC Emerging Frontiers in GLP-1 Therapeutics 2025 PMC SGLT2 Inhibitors Jardiance & Farxiga: The Diabetes Drug That Protects Your Heart and Kidneys Here is something remarkable

Its main active ingredient, silymarin, has been shown to have antioxidant and anti-inflammatory effects that may protect liver cells

While its topical safety record is strong, its systemic safety and efficacy for treating medical conditions have not been established through comprehensive, large-scale, independent Phase 3 human trials